Skip to main content

SynChem boosts Formosa’s presence

Formosa Laboratories, a Taiwan-based API supplier and CDMO, has completed the acquisition of SynChem, a contract research laboratory located in suburban Chicago. SynChem will now operate as SynChem-Formosa, with Dr W. Paul Mar continuing as CEO. Terms were not disclosed.

Dr Cheng, chairman and president of Formosa, particularly noted SynChem's track record in areas such as ADC payloads and linkers. Added to Formosa’s capabilities in scale-up, commercial GMP production, bio-conjugation and injectable fill-finish operations, he said, “we are now poised to offer comprehensive, fully GMP-compliant CDMO services to our clients across the US and internationally.”

Add new comment

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.